|
| 36373344 | A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial. | Alzheimers Dement | 2023 |
| 37638430 | Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia. | J Alzheimers Dis | 2023 |
| 37279390 | Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease. | Alzheimers Dement | 2023 |
| 34893448 | Design and Development of a Community-Based, Interdisciplinary, Collaborative Dementia Care Program. | Am J Geriatr Psychiatry | 2022 |
| 36120781 | Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil. | J Alzheimers Dis | 2022 |
| 36281659 | Editorial: Blood-Based Biomarkers for Alzheimer's Disease: Are We There Yet? | J Prev Alzheimers Dis | 2022 |
| 35065031 | Pimavanserin and dementia-related psychosis. | Lancet Neurol | 2022 |
| 35212149 | Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease. | Alzheimers Dement | 2022 |
| 35103388 | Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial. | Alzheimers Dement | 2022 |
| 31230490 | Normative data stratified by age and education for a Spanish neuropsychological test battery: Results from the Colombian Alzheimer's prevention initiative registry. | Appl Neuropsychol Adult | 2021 |
| 33617650 | Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease. | J Neuropathol Exp Neurol | 2021 |
| 34548654 | The case for low-level BACE1 inhibition for the prevention of Alzheimer disease. | Nat Rev Neurol | 2021 |
| 34463747 | Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian Cohort. | JAMA Netw Open | 2021 |
| 34252876 | PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriers. | Neuroimage Clin | 2021 |
| 34289275 | Trial of Pimavanserin in Dementia-Related Psychosis. | N Engl J Med | 2021 |
| 33978638 | Erratum to: HARMONY Study: Pimavanserin Significantly Prolongs Time to Relapse of Dementia-Related Psychosis. | Innov Aging | 2021 |
| 31401841 | Impact of Zumba on Cognition and Quality of Life is Independent of APOE4 Carrier Status in Cognitively Unimpaired Older Women: A 6-Month Randomized Controlled Pilot Study. | Am J Alzheimers Dis Other Demen | 2020 |
| 31874859 | Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease. | J Neurol Neurosurg Psychiatry | 2020 |
| 31831374 | Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele. | Alzheimers Dement | 2020 |
| 31764959 | Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials. | JAMA Neurol | 2020 |
| 33253354 | BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain. | Brain | 2020 |
| 33049114 | Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease. | Alzheimers Dement | 2020 |
| 32925067 | Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study. | J Alzheimers Dis | 2020 |
| 32611637 | Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers. | Neurology | 2020 |
| 32418361 | Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial. | Alzheimers Dement | 2020 |
| 32470423 | Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study. | Lancet Neurol | 2020 |
| 32460855 | The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease. | Alzheimers Res Ther | 2020 |
| 30636738 | Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease. | J Alzheimers Dis | 2019 |
| 31921963 | Alzheimer's Prevention Initiative Generation Program: Development of an <i>APOE</i> genetic counseling and disclosure process in the context of clinical trials. | Alzheimers Dement (N Y) | 2019 |
| 31686034 | Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. | Nat Med | 2019 |
| 31387606 | Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's disease. | Alzheimers Res Ther | 2019 |
| 31211217 | The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease. | Alzheimers Dement (N Y) | 2019 |
| 31237877 | Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease. | PLoS One | 2019 |
| 31193334 | Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease. | Alzheimers Dement (N Y) | 2019 |
| 30741683 | Present Algorithms and Future Treatments for Alzheimer's Disease. | J Alzheimers Dis | 2019 |
| 30772251 | GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies. | Alzheimers Dement | 2019 |
| 30970186 | Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease. | N Engl J Med | 2019 |
| 30756114 | Assessment of Clinical Meaningfulness of Endpoints in the Generation Program by the Insights to Model Alzheimer's Progression in Real Life (iMAP) Study. | J Prev Alzheimers Dis | 2019 |
| 29318278 | Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials. | JAMA | 2018 |
| 30090848 | Adherence/Retention Alzheimer's Prevention Initiative Colombia Plan. | Alzheimers Dement (N Y) | 2018 |
| 29955659 | The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort. | Alzheimers Dement (N Y) | 2018 |
| 30474567 | Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program. | Alzheimers Res Ther | 2018 |
| 30298184 | Pimavanserin: Potential Treatment For Dementia-Related Psychosis. | J Prev Alzheimers Dis | 2018 |
| 29719179 | Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease. | N Engl J Med | 2018 |
| 29405233 | The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial. | J Prev Alzheimers Dis | 2018 |
| 29435558 | Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease. | JAMA Neurol | 2018 |
| 28688021 | Inaugural Conference on Incorporating Patient-Reported Outcomes and Patient Preference Information into Clinical Research, Clinical Care, and Risk-Benefit Assessments for Neurodegenerative Diseases. | Patient | 2017 |
| 31997970 | Guideline Watch (October 2014): Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. | Focus (Am Psychiatr Publ) | 2017 |
| 28323826 | APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts. | PLoS Med | 2017 |
| 29181489 | The Alzheimer's Prevention Initiative Generation Program: Evaluating CNP520 Efficacy in the Prevention of Alzheimer's Disease. | J Prev Alzheimers Dis | 2017 |